Saturday, March 14, 2026
31.7 C
Bengaluru

Ashok Nair, Managing Director of Abbott India in Conversation with MedicinMan

https://www.credoweb.in/discussion/661/new-growth-drivers-for-indian-pharma-companies

Ashok Nair began his career as a Medical Rep and rose to become the Managing Director of one of India’s most admired pharma companies – Abbott India.

In this conversation, Ashok Nair shares his perspectives on the challenges ahead and what Indian Pharma needs to do, to face them effectively.

Register now to receive your invitation to the webinar on 1st May 2021

Over 20 pharma leaders have shared their perspectives on various aspects of pharma business, you can register and view them at any time on

www.credoweb.in

Hot this week

IPM Powers Ahead in 2026: 11% Growth Fueled by Cardiac, Anti-Diabetics, and GLP-1 Stars

India's pharmaceutical market charged into 2026 with strong momentum,...

How Smart Medical Reps Can Beat Bots

Today's Brand Equity cover — a woman lost in...

Nutraceuticals: Health, Hope Or Hype?

Walk into almost any clinic today and you will...

When Biology Beats Willpower: The Rise of GLP‑1/GIP Therapies

“Lifestyle advice often asks patients to fight powerful evolutionary...

The Antifungal Blind Spot: India’s Quiet Clinical Crisis

A market analysis and clinical commentary on the growing...

Topics

How Smart Medical Reps Can Beat Bots

Today's Brand Equity cover — a woman lost in...

Nutraceuticals: Health, Hope Or Hype?

Walk into almost any clinic today and you will...

When Biology Beats Willpower: The Rise of GLP‑1/GIP Therapies

“Lifestyle advice often asks patients to fight powerful evolutionary...

The Antifungal Blind Spot: India’s Quiet Clinical Crisis

A market analysis and clinical commentary on the growing...

Elephant in the Doctor’s Clinic: Indian Pharma Medical Rep

For decades, the Medical Representative has been the backbone...
spot_img

Related Articles

spot_imgspot_img